# Real-world Data in Patients With Breast Cancer Treated With Abemaciclib

> **NCT04985058** · — · RECRUITING · sponsor: **Hellenic Cooperative Oncology Group** · enrollment: 108 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04985058
- **Lead sponsor:** Hellenic Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-06
- **Primary completion:** 2026-11-30
- **Final completion:** 2027-07-01
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04985058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04985058, "Real-world Data in Patients With Breast Cancer Treated With Abemaciclib". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04985058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*